Similar Papers

Paper Title
Journal
Date
Author
Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis
Johannes Laengle ... Julijan Kabiljo
Journal for ImmunoTherapy of Cancer | VOL. 8
Johannes Laengle, et. al.Johannes Laengle ... Julijan Kabiljo
01 Jan 2020
Effect of epigenetic treatment on SST2 expression in neuroendocrine tumour patients.
Julie Refardt ... Leo J Hofland
Clinical and Translational Medicine | VOL. 12
Julie Refardt, et. al.Julie Refardt ... Leo J Hofland
01 Jul 2022
Effects of the Histone Deacetylase Inhibitor Valproic Acid on Human Pericytes In Vitro
Jakob Karén ... Jeffrey M Gimble
PLoS ONE | VOL. 6
Jakob Karén, et. al.Jakob Karén ... Jeffrey M Gimble
22 Sep 2011
Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation
Akiyama
International Journal of Oncology | VOL. 37
Akiyama Akiyama
01 Sep 2010
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Cancer-Specific Utility Instrument for Health Economic Evaluations: A Synopsis of the EORTC QLU-C10D User Manual and Current Validity Evidence
Simone Seyringer ... Eva M Gamper
European Journal of Cancer | VOL. -
Simone Seyringer, et. al.Simone Seyringer ... Eva M Gamper
01 Jan 2025
Editorial Board
-
European Journal of Cancer | VOL. 215
--
01 Jan 2025
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 results
Annalisa Trama ... Salvatore Provenzano
European Journal of Cancer | VOL. -
Annalisa Trama, et. al.Annalisa Trama ... Salvatore Provenzano
01 Jan 2025
Characteristics and outcomes in patients with lenalidomide-refractory multiple myeloma treated with 1-3 prior lines of therapy: analysis of individual patient-level data from daratumumab clinical trials
Kwee Yong ... Binod Dhakal
European Journal of Cancer | VOL. 215
Kwee Yong, et. al.Kwee Yong ... Binod Dhakal
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.